Health
COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials – BBC Focus Magazine
Scientists at Cambridge say they aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses.
A coronavirus vaccine candidate developed by the University of Cambridge could begin clinical trials in the UK in the autumn.
A £1.9 million funding boost from Innovate UK, the governments innovation agency, has provided support for a collaboration between Cambridge spin-out company DIOSynVax, the University of Cambridge and the University Hospital Southampton NHS Foundation Trust.
The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University…
-
Noosa News20 hours agoStudents say new facility would be better in rural areas of Queensland
-
General14 hours ago‘We are here for you’: PM to bring help to flood zones
-
General12 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General9 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains